Skip to Content
 

News: November, 2023

Q+A: Uterine Cancer

Thursday, November 30th, 2023

The most common cancer of the female reproductive organs is uterine cancer, and its incidence is growing Q What causes uterine cancer?  A The most common type of uterine cancer is caused by an imbalance in the hormones estrogen and progesterone. Estrogen is produced during the first part of the menstrual cycle and causes the […]

Holowatyj receives NCI MERIT award

Thursday, November 30th, 2023

Andreana Holowatyj, PhD, MSCI, assistant professor of Medicine, has received the National Cancer Institute’s Method to Extend Research in Time (MERIT) Award to support her ongoing investigation into how early-onset colorectal cancer and its treatments impact reproductive health.  This award is one that investigators cannot apply for directly. They are selected by National Cancer Institute […]

Emerging Technology & Talent

Thursday, November 30th, 2023

The 24th annual Vanderbilt-Ingram Cancer Center Scientific Retreat focused on emerging technologies in research and celebrated the next generation of investigators.   The guest speakers detailed initiatives about creating comprehensive reference maps for all human cells, exploring new frontiers for CAR T-cell therapies, and utilizing artificial intelligence to better understand protein structures and interactions. The Vanderbilt-Ingram […]

A silly song

Thursday, November 30th, 2023

Try to sing this to the tune of “Supercalifragilisticexpialidocious:”  Auto-immune slash cancer disease With a half-decent prognosis Plays hell with my skin and Gave to me a brain tumor atrocious At least of all these nasty things I don’t have halitosis I have got the Langerhans Cell Histiocytosis! Um-dittle-ittl I’m not gonna die Um-dittle-ittl I’m not gonna die  LCH is my rare disease. […]

Research that’s Practice Changing Paradigm Shifting & Policy Creating

Thursday, November 30th, 2023

The challenge to accomplish “practice-changing, paradigm-shifting, policy-creating” research is one that scientists and clinicians at Vanderbilt-Ingram Cancer Center have often heard from Jennifer Pietenpol, PhD. Those words are like a mantra for Pietenpol, Executive Vice President for Research, chief scientific and strategy officer for Vanderbilt University Medical Center (VUMC) and holder of the Brock Family […]

On the Ball

Thursday, November 30th, 2023

This summer, Jim Delany took the Queen Mary 2 from New York City to Southampton, England, with his brother, spent three days in London, four days in the Dordogne region of France and two days in Paris. He returned to Nashville just in time for his second infusion of PluvictoTM, a radioactive drug therapy targeted […]

Destination Care

Thursday, November 30th, 2023

J.D. Anderson, a 64-year-old cattle producer from Arapahoe, Nebraska, who has been battling stage 4 colon cancer since 2012, has made the 28-hour round trip to Vanderbilt-Ingram Cancer Center, often monthly, over the past four years.  For the past three years, 5-year-old Jackson Simpson of Charlotte, North Carolina, has been receiving treatment for hepatoblastoma, a […]

3D Ingenuity

Thursday, November 30th, 2023

Three-dimensional scanning and printing systems are now utilized for purposes ranging from same-day dental crowns to prosthetic limbs, so Michael Topf, MD, wondered why computer-aided design (CAD) technology hadn’t made it into operating rooms as a visual aid for real-time consultations.  Surgeons communicate via phone and are dependent upon verbal descriptions from pathologists for guidance […]

Journal Watch

Thursday, November 30th, 2023

Clue to gastric cancer discovered Fibroblast cells play key roles in the repair of damaged tissue and in pathological scarring. James Goldenring, MD, PhD, and colleagues have uncovered evidence of their direct involvement in the development of gastric cancer. The findings, published May 15 in the journal Gastroenterology, could lead to novel interventions to prevent […]

Shared Experience

Thursday, November 30th, 2023

At the age of 13, Jason Schwartz made a life-changing decision. Amid cancer treatment for acute lymphoblastic leukemia, Schwartz was handed an incredible gift that would fuel his life’s work.  “I developed a great relationship with my tutor,” recalled Schwartz. “Dennis was his name. I remember that I didn’t always feel so great, and schoolwork […]

Next Page »